The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of hiv-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 6, Issue 11, 1993, Pages 1248-1257

  Birx, Deborah L ^a   Brundage, John ^b   Larson, Kristin ^c   Engler, Renata ^d   Smith, Laurie ^d   Squire, Edward ^d   Carpenter, Gary ^d   Sullivan, Michael ^d   Rhoads, Joanne ^e   Oster, Charles ^e   James, William ^f   Lupton, George ^g   Wierzba, Thomas ^h   Burke, Donald ^a   Redfield, Robert ^a  

^a Department of Retroviral Research Division of Retrovirology ^*  (United States)

^b Department of Preventive Medicine WRAIR ^*  (United States)

^c SRA International   (United States)

^d Allergy ImmunoIogy Service ^*  (United States)

^e Infectious Disease Service   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^h H M Jackson Found Adv Mil Med   (United States)

Author keywords

Anergy; Delayed type hypersensitivity skin testing; Hiv disease; Prognosis

Indexed keywords

CANDIDA ANTIGEN; CD4 ANTIGEN; TETANUS TOXOID; TUBERCULIN; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUMPS VIRUS; PROGNOSIS; SKIN TEST;

ADULT; ALGORITHMS; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMAN; HYPERSENSITIVITY, DELAYED; LEUKOCYTE COUNT; MALE; MILITARY PERSONNEL; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; SKIN TESTS;

EID: 0027361830     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Turk JL. Delayed hypersensitivity. Amsterdam: North- Holland Publishing Co.. 1975.
2. Mantoux C. lntradermo-reaction de la tuberculine. CRAcad Sci 1908:147:355-357.
3. Zinsser H. Mueller JH. On the nature of bacterial allergies. J Exp Med 1925:41:159-177.
4. Jones TD. Mote JR. The phases of foreign protein sensitiza¬tion in human beings. New Engl J Med 1934;210:120-123.
5. Dvorak HF. Cutaneous basophil hypersensitivity. J Allergy Clin Immunol 1976:58:229-240.
6. Johnson EJ. Manseau EM. Colvin R. Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest 1974: 31:111-130.
7. Platt JL, Grant BW. Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-typed hypersensitivity. J Exp Med 1983:158:1227-1242.
8. Kirkpatrick CH. Delayed hypersensitivity. In: Samter M, ed. Immunologic discuses, 4th ed. Boston: Little, Brown and Co.. 1988:11:270-273.
9. Waldmann TA. Immunodeficiency diseases: primary and acquired. In: Samter M. ed. Immunological disease. Boston: Little. Brown, and Co., 1988:411-465.
10. Schubert WK. Fowler R, Martin LW. West CD. Homograft rejection in children with congenital immunologic defects: agammaglubulinemia and Aldrich syndrome. Trans Bull 1960:26:125-128.
11. Catalona WJ. Taylor PT, Chrieten PB. Quantitative dinitro- chlorobenzene contact sensitization in a normal population. Clin Exp Immunol 1972:12:325-333.
12. Buckley CE. White DH. Aging and immunocompetence skin testing: recent advances in gerontology. Proceedings of the 1 Ith International Congress of Gerontology, 1979:444-449.
13. Buckley CE. Delayed hypersensitivity skin testing. In: Rose NR. Friedman H. Fahey JL, ed. Manual of clinical laboratory immunology, 3rd ed. Washington, D.C.: American So¬ciety for Microbiology. 1986;37:260-273.
14. Gottlieb MS. Groopman JE. Weinstein WM, Fahey JL, Birx DL. The acquired immunodeficiency syndrome. Ann Intern Med 1986:99:208-220.
15. Bates SE. Suen JY. Tranum BL. Immunological skin testing and interpretation. Cancer 1979;43:2306-2314.
16. Bearman JE, Kleinman H. Glyver VV, LaCroix OM. A study of variability in tuberculin test reading. Am Rev Respir Dis 1964:90:913-919.
17. Ahmed AR, Blose DA. Delayed type hypersensitivity skin testing. Archiv Dermatol 1983;119:934-945.
18. Delafuente JC, Eisenberg JD. Hoelzer DR. Slavin RG. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity. JAMA 1983;249:3209-3211.
19. Franz MJ, Carella JA, Galant SP. Cutaneous delayed hypersensitivity in a healthy pediatric population. J Pediatr 1976: 88:975-977.
20. Israel RH, Anantharaman A, Schuster B, Magnussen CR. Delayed hypersensitivity skin testing: variability of physi¬cian interpretation. Archiv Intern Med 1981:141:1723
21. Fairshter RD. Thornton DB, Gottschalk HR. Slater LM, Galant SP. In vivo and in vitro cell-mediated immunity to tetanus toxoid in adults. J Allergy Clin Immunol I980;66: 452-457.
22. Gordon EH. Krouse HA, Kinney JL. Stiem ER. Klauster WB. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell- mediated immunity. J Allergy Clin Immunol 1983;72:487-494.
23. Siegal FP. Normal delayed-type skin reactions in early stages of acquired cellular immunodeficiency. New Engl J Med 1982:307:184.
24. Weber JN, Rogers LA, Scott K, et al. Three-year prospec¬tive study of HTLV-11I/LAV infection in homosexual men. Lancet 1986;1:1179-1182.
25. Siegal FP, Lopez C, Fitzgerald PA, et al. Opportunistic in¬fections in AIDS result from synergistic defects of both the natural and adaptive components of cellular immunity. Clin Invest 1986:78:115-23.
26. Brettler DB, Forsberg AD, Brewster F, Sullivan JL. Levine PH. Delayed cutaneous hypersensitivity reactions in hemo¬philiac subjects treated with factor concentrate. Am J Med 1986:81:607-611.
27. Frazer lH, Mackay lR, Crapper RM, et al. Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-1II and sequential changes over two years. Quart J Med 1986:234:921-933.
28. Sears SD. Fox R. Brookmeyer R, Leavitt R, Polk BF. De¬layed Hypersensitivity Skin Testing and Anergy in a Popu¬lation of Gay Men. Clin Immunol Immunopathol 1987;45: 177-183.
29. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-lll/LAV infection. New Engl J Med 1986:314:131-2.
30. Sokel JE. Measurement of delayed skin test responses. New Engl J Med 1975;293:501-502.
31. Rickman WJ, Waxdal MJ, Monical C, Damato JD, Burke DS. Department of Army Lymphocyte Immunophenotyping Quality Assurance Program. Clin Immunol Immunopathol 1989;52:85-95.
32. Klein RS, Harris CA. Small CB, Moll B, Lesser M, Fried- land GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency. New Engl J Med 1984;311:354-358.
33. MacDonnell KB, Chmiel JS, Goldsmith J, et al. Prognostic usefulness of the Walter Reed staging classification for HIV infection. J Acquir Immune Dejic Syndr 1988;1:367-374.
34. Frazier TC, Wagner JM, Wray BB, Stafford CT. Multitest CM1 skin test compared with standard intradermal skin testing in evaluation of cell-mediated immunity. J Allergy Clin Immunol 1993;91:213.
35. Center for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991 ;40:37-43.